GSK and Lyell Immunopharma have announced a five-year collaboration to develop new technologies with the aim of improving cell therapies for cancer patients. In the announcement the companies explained that the collaboration will apply Lyell’s technologies to further strengthen GSK’s cell therapy pipeline, including GSK3377794, which targets the NY-ESO-1 antigen that is expressed across multiple
Novartis and Microsoft have announced a new collaboration with the aim to “transform medicine with artificial intelligence.” Novartis announced the “important step in reimagining medicine” by founding the Novartis AI innovation lab, choosing Microsoft as its strategic AI and data-science partner. The company says that the new lab will look to bolster Novartis AI capabilities
The University has established a new institute to obtain earlier diagnosis of cancer, cardiovascular disease, mental health and infection and help address current inequalities. Early diagnosis is critical in order to achieve the best treatment outcomes, yet diseases are much more likely to be diagnosed earlier in affluent areas compared to Scotland’s most deprived communities.
